文献速递神经肿瘤

超大与巨大垂体腺瘤的临床表现与手术结局:306例垂体腺瘤队列研究中的80例分析

Clinical presentation and surgical outcomes of very large and giant pituitary adenomas: 80 cases in a cohort study of 306 patients with pituitary adenomas.
PubMed 文献 · Acta Neurochir (Wien) · 2024-05-21

该队列研究比较了2008至2023年间接受肿瘤切除术的80例超大(30-39 mm)或巨大(≥40 mm)垂体腺瘤(LARGE组)与226例较小(<30 mm)垂体腺瘤(非LARGE组)的临床表现与手术结局。LARGE组术前视觉障碍、垂体卒中、全垂体功能减退及海绵窦侵犯更常见,手术治愈率更低(50.0% vs 79.7%),主要并发症发生率更高(8.8% vs 1.3%)。

要点

  • LARGE组术前视觉障碍(82.5% vs 22.1%)与垂体卒中(15.0% vs 2.7%)均显著多于非LARGE组。
  • LARGE组海绵窦侵犯(71.3% vs 23.9%)与全垂体功能减退(28.8% vs 6.2%)均显著多于非LARGE组。
  • 非LARGE组手术治愈率79.7%高于LARGE组50.0%,LARGE组主要并发症8.8%高于非LARGE组1.3%。

核心结论

  • ≥30 mm的垂体腺瘤常伴激素功能障碍、海绵窦侵犯和视觉障碍,导致切除率更低、术后并发症更高,构成真实的手术挑战。

研究设计与样本

  • 队列研究,纳入2008年至2023年间接受垂体手术肿瘤切除的80例超大(30-39 mm,n=44)或巨大(≥40 mm,n=36)垂体腺瘤患者(LARGE组)及226例较小(<30 mm)垂体腺瘤患者(非LARGE组),评估激素、影像、眼科、病理资料及手术结局。

主要发现

  • LARGE组术前视觉障碍82.5% vs 非LARGE组22.1%(P < 0.001)。
  • LARGE组术前垂体卒中15.0% vs 非LARGE组2.7%(P < 0.001)。
  • LARGE组术前全垂体功能减退28.8% vs 非LARGE组6.2%(P < 0.001)。
  • LARGE组海绵窦侵犯71.3% vs 非LARGE组23.9%(P < 0.001)。
  • 非LARGE组手术治愈79.7% vs LARGE组50.0%(P < 0.001);LARGE组主要并发症8.8% vs 非LARGE组1.3%(P < 0.004)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To identify differences in the presentation and surgical outcomes between very large (30-39 mm) and giant (≥ 40 mm) (LARGE group) pituitary adenomas (PAs) compared to the smaller group (< 30 mm) (non-LARGE group). METHODS: Eighty patients with very large (n = 44) or giant (n = 36) PAs and 226 patients in the non-LARGE group who underwent tumor resection by pituitary surgery between 2008 and 2023 were studied. Hormonal, radiological, ophthalmological, and pathological data, and surgical outcomes were evaluated. RESULTS: Preoperatively, patients of the LARGE group presented more frequently with visual impairment (82.5% vs. 22.1%, P < 0.001) and with pituitary apoplexy (15.0% vs. 2.7%, P < 0.001) than the non-LARGE group. Moreover, the LARGE group were more commonly associated with preoperative panhypopituitarism (28.8% vs. 6.2%, P < 0.001). This group presented cavernous sinus invasion more frequently (71.3% vs. 23.9%, P < 0.001). The non-LARGE group achieved surgical cure more often than the LARGE group (79.7% vs. 50.0%, P < 0.001), and the rate of major complications was higher in the latest (8.8% vs. 1.3%, P < 0.004). CONCLUSIONS: PAs ≥ 30 mm are most frequently accompanied by hormonal dysfunction, cavernous sinus invasion, and visual impairment. All this implies lower resection rates and higher postoperative complications than the smaller adenomas, posing a real surgical challenge.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Pascual-Corrales E, Acitores Cancela A, Baonza G, et al. Clinical presentation and surgical outcomes of very large and giant pituitary adenomas: 80 cases in a cohort study of 306 patients with pituitary adenomas. Acta Neurochir (Wien). 2024. PMID: 38772927. doi:10.1007/s00701-024-06107-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。